glossary_check
TL2 Member · Bratislava, SK
Practical questions, practical answers. Not interested in speculation without a source.
Joined 1 August 2025 · last posted 17h
103 posts, newest first. Showing up to 150.
-
Sleep apnoea improving and the equipment implications Replied, post #19 · Wellbeing › Sleep · 27 Jul 2026 · 3 likes Agreed on all of that, and I have nothing to add to it.
-
A community side-effect dataset, with its response rate and biases Replied, post #3 · marked as the solution · Data & Tools › Datasets · 27 Jul 2026 · 7 likes How to contribute: if you have longitudinal data you want to add, the format is simple: date, measurement, context. Contact the maintainer of the specific dataset. One…
-
What steady state means for the decision to escalate Replied, post #36 · Practice › Dosing & titration · 27 Jul 2026 · 0 likes There is no published evidence about slower escalation because nobody studied it. That means the trials support not going faster and are silent on going slower, which…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #76 · Practice › Administration · 25 Jul 2026 · 9 likes Post #75 answers the question as asked. The question underneath it is different. Filing a mild objection to the consensus on completing a dose. Mild because I might be…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #109 · Sourcing › Independent verification · 20 Jul 2026 · 3 likes Answering the question post #107 raises rather than the one it answers. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #76 · Practice › Dosing & titration · 18 Jul 2026 · 32 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
CJC-1295 with and without DAC: what the modification does Replied, post #115 · Compounds › Secretagogues & GH axis · 18 Jul 2026 · 0 likes CJC-1295 exists in two forms in circulation — with and without the drug affinity complex — and they have very different half-lives. Product descriptions frequently do…
-
[2026 update] Documenting an adverse event properly Replied, post #12 · Safety › Adverse events · 17 Jul 2026 · 6 likes Post #8 put the caveat in the right place and I want to underline it. Attribution is genuinely hard for a single case and the reporting schemes are designed to work…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #83 · Start Here › Welcome · 14 Jul 2026 · 3 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #70 · Outcomes › Progress reports · 5 Jul 2026 · 1 like Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
-
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Replied, post #18 · Evidence › Journal club · 1 Jul 2026 · 2 likes Building on post #17 rather than restating it. Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last.…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #59 · Evidence › Journal club · 25 Jun 2026 · 14 likes Adding the measurement that post #56 says would settle it. The most common failure mode is spending fifty minutes on the effect size and ten on the population.…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #16 · Analytics › Home & field testing · 21 Jun 2026 · 22 likes I had written a reply contradicting post #13 and deleted it. Here is what survived. Colorimetric tests: colour intensity correlates with concentration, but the…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #64 · Wellbeing › Sleep · 20 Jun 2026 · 1 like Sleep quality versus quantity: some people report changes to sleep duration; others report changes to sleep quality without duration change. Both can matter for…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #75 · Safety › Contraindications · 16 Jun 2026 · 10 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #6 · Analytics › Home & field testing · 13 Jun 2026 · 0 likes I think the Cost versus information question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Racemisation and why it is invisible to a mass measurement Replied, post #67 · Analytics › Impurities & related substances · 12 Jun 2026 · 2 likes Picking up post #66: that is the part I would want checked first. Trifluoroacetate is a counter-ion rather than an impurity, and it appears in the mass balance rather…
-
Why the timeline is on the right and not the left — what changed since Replied, post #52 · Meta › Site feedback · 10 Jun 2026 · 5 likes On post #48 — agreed on the reasoning, with one qualification. Feedback on the trust-level page: it explains what each level unlocks, and not what a member at that…
-
The most useful thing you learned here that was not the answer you came for Replied, post #45 · Lounge › Off topic · 25 May 2026 · 0 likes Adjacent thought. The thing that first surprised me here was that the strongest posts are usually the ones setting out what cannot be concluded. Everywhere else that…
-
Blinding yourself: practical methods and their limits Replied, post #24 · Research Methods › N-of-1 designs · 9 May 2026 · 0 likes Blinding yourself is harder than it sounds and is not impossible. Somebody else preparing labelled containers is the usual approach and it requires a second person you…
-
Amylin receptor signalling and satiety — what changed since Replied, post #75 · Pharmacology › Receptor biology · 7 May 2026 · 10 likes GIP receptor biology is genuinely contested. Both agonism and antagonism have been argued to produce weight reduction, and the fact that the field can hold both…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #71 · Outcomes › Body composition · 6 May 2026 · 3 likes Noted, and thank you for writing it out rather than summarising it.
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #121 · Analytics › Mass spectrometry · 28 Apr 2026 · 1 like Everything in post #118 holds. The case it does not cover is the one I have. Trying to state the Charge states position in a way that someone who disagrees would…
-
Prescription requirements and telehealth models — a second dataset Replied, post #13 · Sourcing › Regulatory · 27 Apr 2026 · 20 likes A note on how Prescription requirements and telehealth models gets discussed rather than on Prescription requirements and telehealth models itself: the confident posts…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #100 · Practice › Reconstitution · 24 Apr 2026 · 3 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
What a certificate commits its issuer to — one year on Replied, post #54 · Analytics › COA interpretation · 22 Apr 2026 · 21 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #110 · Analytics › Mass spectrometry · 16 Apr 2026 · 28 likes Sensible. I would want the same detail before I acted on it either.
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #28 · Analytics › Impurities & related substances · 16 Apr 2026 · 27 likes Confirming post #27 from a second method, which matters more than confirming it from a second person. An impurity profile that changes between lots is more informative…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #92 · Practice › Reconstitution · 9 Apr 2026 · 0 likes What I would tell a new member reading about Foaming during reconstitution for the first time: the confident posts are not the reliable ones, and the reliable ones are…
-
Revisiting: Absolute versus relative contraindications Replied, post #62 · Safety › Contraindications · 9 Apr 2026 · 8 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either. It is the kind of thing that is…
-
List price versus negotiated price versus what you pay Replied, post #16 · Access › Pricing · 9 Apr 2026 · 2 likes Where somebody posts a comparison, the useful version states the date, the region and what was included.
-
Journal club: is percentage weight change the right endpoint? Replied, post #49 · Evidence › Journal club · 8 Apr 2026 · 12 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
-
About the Preprints category Replied, post #6 · Evidence › Preprints · 2 Apr 2026 · 0 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…
-
Adjudicated events and why the definition matters Replied, post #2 · Evidence › Trials · 25 Mar 2026 · 20 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
Follow-up: Search filters: what is missing Replied, post #47 · Meta › Site feedback · 6 Mar 2026 · 0 likes Sensible. I would want the same detail before I acted on it either.
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #57 · Pharmacology › Pharmacokinetics · 1 Mar 2026 · 0 likes Practical note on Washout: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
-
Measurement error in a self-reported exposure Replied, post #106 · Evidence › Study critique · 27 Feb 2026 · 24 likes Post #105 answers the question as asked. The question underneath it is different. Two sentences on measurement error and then I will stop, because the rest is…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #73 · Analytics › Mass spectrometry · 14 Feb 2026 · 19 likes Mass error in ppm is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
-
Trifluoroacetate content and its consequences Replied, post #64 · Analytics › Impurities & related substances · 1 Feb 2026 · 0 likes Checked the trifluoroacetate content claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
-
A fridge failure and how I assessed the contents afterwards Started this topic · Devices › Cold chain · 25 Jan 2026 · 43 likes A fridge failure and how I assessed the contents afterwards Writing it up because I had to work it out twice and would rather nobody else did. The question about fridge…
-
Publication bias detection and its low power — does this still hold? Replied, post #6 · Evidence › Meta-analyses · 10 Jan 2026 · 0 likes Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
-
A partial dose because the pen emptied mid-injection Replied, post #57 · Practice › Administration · 9 Jan 2026 · 8 likes Small correction to my own earlier position on partial dose because the pen. I had the units the wrong way round, which changes the conclusion by an order of magnitude…
-
Aggregates and why a purity assay may miss them entirely Replied, post #31 · Analytics › Impurities & related substances · 27 Dec 2025 · 14 likes This is the sort of exchange that makes the archive worth searching.
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #119 · Documentation › Doc review · 25 Dec 2025 · 1 like Taking post #118 at face value and following it one step further. The most useful review comment names a sentence and says what is wrong with it. General approval and…
-
Lipase elevation without symptoms: the interpretation problem Replied, post #17 · Clinical › Bloodwork · 18 Dec 2025 · 0 likes The arithmetic in post #14 is right; the assumption feeding it is the part to check. Where a panel includes a calculated value, that value inherits the imprecision of…
-
Publishing an inconvenient result: a case study — the long version Replied, post #69 · Sourcing › Independent verification · 13 Dec 2025 · 8 likes Post #66 and I disagree about the size of the effect, not about the direction. Where two services agree with each other and with the declared figure, that is a…
-
About the Statistics category Replied, post #8 · Research Methods › Statistics · 9 Dec 2025 · 16 likes A distribution shown is worth ten summary statistics. Where a paper shows individual data points, read those first.
-
Journal club: PIONEER 6 as a safety trial Replied, post #10 · Evidence › Journal club · 4 Dec 2025 · 2 likes Post #6 and I disagree about the size of the effect, not about the direction. What I would check first on PIONEER 6 is whether the thing being measured moved or whether…
-
Amylin receptor signalling and satiety — what changed since Started this topic · Pharmacology › Receptor biology · 30 Nov 2025 · 48 likes On the subject in the title: Amylin receptor signalling and satiety — what changed since Working notes rather than a conclusion. What changes if the standard account of…
-
Comparing two chromatograms from different laboratories, properly Replied, post #33 · Analytics › HPLC & UHPLC · 22 Nov 2025 · 8 likes I read post #32 twice before replying, because I had assumed the opposite. A shallow gradient resolves close-eluting species that a steep one merges. Two honest…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #12 · Data & Tools › Calculators · 19 Nov 2025 · 19 likes Dose-equivalence calculators between compounds should be treated with real suspicion, because equivalence between these compounds has not been established in the way…
-
Revisiting: Absolute versus relative contraindications Replied, post #5 · Safety › Contraindications · 14 Nov 2025 · 1 like Where a contraindication is relative rather than absolute, the reasoning usually appears in the assessment report rather than the labelling.
-
Moderation log format change Replied, post #8 · Meta › Announcements · 13 Nov 2025 · 5 likes Coming back to post #6, because the follow-up matters more than the original answer. The rare case here is the one that costs somebody a week, though, and the common…
-
MHRA statements, read directly Replied, post #24 · Regional › UK & Ireland · 31 Oct 2025 · 0 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Gauge and length selection for subcutaneous injection Replied, post #44 · Devices › Syringes & needles · 27 Oct 2025 · 13 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum. It is the…
-
New subcategory: rationale and scope Replied, post #48 · Meta › Announcements · 17 Oct 2025 · 10 likes A definition problem is doing most of the work in this new subcategory discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is…
-
Sleep tracking data and its considerable limitations Replied, post #10 · Wellbeing › Sleep · 16 Oct 2025 · 11 likes Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to months, not immediate. Improvement often is gradual rather than…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #36 · Start Here › Welcome · 15 Oct 2025 · 5 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #15 · Meta › Announcements · 8 Oct 2025 · 23 likes Post #14 put the caveat in the right place and I want to underline it. Distinguishing three things in the Scheduled maintenance discussion that keep getting used…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #32 · Wellbeing › Mental health · 30 Sep 2025 · 2 likes A note on how Anxiety gets discussed rather than on Anxiety itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have been…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #117 · Compounds › Retatrutide · 25 Sep 2025 · 9 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
[2026 update] Long-time reader, first-time poster Replied, post #8 · Lounge › Introductions · 1 Sep 2025 · 0 likes Introductions are also a reasonable place to say what you are hoping to find, because somebody will usually know whether it exists here already. Anyone who has looked…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #31 · Practice › Dosing & titration · 25 Aug 2025 · 25 likes I had written a reply contradicting post #29 and deleted it. Here is what survived. Dose and effect are not linear across the studied range for every compound in this…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #96 · Compounds › Secretagogues & GH axis · 24 Aug 2025 · 0 likes On post #94 — agreed on the reasoning, with one qualification. Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #51 · Evidence › Journal club · 17 Aug 2025 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
[2026 update] Splitting an overlong document into two Replied, post #24 · Documentation › Wiki requests · 14 Aug 2025 · 0 likes Adding the measurement that post #23 says would settle it. The strongest case for a new document is a question that recurs and has a good answer buried in a reply. That…
-
Are there stupid questions here? A staff answer, at length Replied, post #62 · Start Here › Welcome · 11 Aug 2025 · 9 likes The compound pages are the fastest way to find out whether a question has a published answer at all. If the page says the trial is ongoing, that is the honest state of…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #92 · Compounds › Repair & healing peptides · 5 Aug 2025 · 13 likes Reported local reactions are common enough in first-hand accounts here to be worth mentioning and are not characterised in any published series. That is one dataset and…
-
A ten-fold dose error caught before injection — one year on Replied, post #56 · Devices › Syringes & needles · 2 Aug 2025 · 0 likes Taking post #55 at face value and following it one step further. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12…
-
Discussing something you have already been doing — the long version Replied, post #9 · Clinical › Prescriber conversations · 8 Jul 2025 · 1 like Post #5 and I disagree about the size of the effect, not about the direction. Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #77 · Wellbeing › Mental health · 26 Jun 2025 · 20 likes Saving this. It is the version I will quote when the question comes round again.
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #53 · Clinical › Comorbidities · 16 Jun 2025 · 29 likes I read post #49 twice before replying, because I had assumed the opposite. Worth separating Cardiovascular risk as a question about the compound from Cardiovascular…
-
Coming back to: When "no data" is the complete and final answer Replied, post #11 · Compounds › Other compounds · 11 Jun 2025 · 0 likes Picking up post #10: that is the part I would want checked first. How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #11 · Compounds › Semaglutide · 7 Jun 2025 · 2 likes Answering the question post #7 raises rather than the one it answers. On the "does it stop working" question: tolerance in the pharmacological sense is not what the…
-
Checking someone else's arithmetic: a worked example thread Replied, post #52 · Practice › Reconstitution · 29 May 2025 · 13 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. Anyone with a…
-
Pregnancy as an absolute contraindication Replied, post #28 · Safety › Contraindications · 17 May 2025 · 0 likes Anyone posting a contraindication claim should include the source. Without one it circulates and hardens.
-
Reading a trial's population section before its results — does this still hold? Replied, post #112 · Evidence › Trials · 17 May 2025 · 13 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
-
Coverage for the indication versus for the drug Replied, post #50 · Access › Insurance & coverage · 2 May 2025 · 0 likes Taking post #48 at face value and following it one step further. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #9 · Nutrition & Training › Protein & intake · 26 Apr 2025 · 31 likes Picking up post #6: that is the part I would want checked first. Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as…
-
Why plausible mechanism is not evidence of effect Replied, post #6 · Compounds › Repair & healing peptides · 20 Apr 2025 · 19 likes The documentation on plausible mechanism is better than this thread and I say that as someone who has posted in the thread.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #83 · Compounds › Semaglutide · 19 Apr 2025 · 0 likes On SELECT: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here…
-
Residual solvents and scavengers: what is looked for Replied, post #12 · Analytics › Impurities & related substances · 12 Apr 2025 · 9 likes Truncation products are substantially lower in mass and usually well separated chromatographically, which makes them the easiest class to see and the least likely to be…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #100 · Documentation › Doc review · 11 Apr 2025 · 2 likes Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so the maintainers notice. The literature is thinner on…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #16 · Practice › Storage & stability · 5 Apr 2025 · 0 likes My experience of published stability data actually covers contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #138 · Sourcing › Vendor reports · 19 Mar 2025 · 14 likes Where you submitted more than one vial from a consignment, say so. Intra-consignment comparison is one of the more useful things an individual can contribute. Not…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #75 · Sourcing › Regulatory · 3 Mar 2025 · 19 likes Building on post #74 rather than restating it. Adding what did not work for me on pharmaceutical compounding rules, since the failures never get written up and they are…
-
Protein density versus volume when you cannot eat much Replied, post #83 · Nutrition & Training › Protein & intake · 7 Feb 2025 · 12 likes This follows post #82 rather than contradicting it. The mechanism is not mysterious. Substantial energy restriction with inadequate protein and no resistance stimulus…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #114 · Evidence › Journal club · 3 Feb 2025 · 1 like The arithmetic in post #113 is right; the assumption feeding it is the part to check. SURPASS-2 is worth one more sentence than it usually gets, and the sentence is the…
-
What we do not know about retatrutide, listed explicitly Replied, post #55 · Compounds › Retatrutide · 14 Jan 2025 · 0 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Follow-up: Individual participant data versus aggregate data Replied, post #80 · Evidence › Meta-analyses · 11 Jan 2025 · 25 likes The strongest argument against my own position on Individual participant data versus aggregate, stated as well as I can state it, since nobody else has yet.
-
[2026 update] New subcategory: rationale and scope Replied, post #111 · Meta › Announcements · 1 Jan 2025 · 4 likes That matches what I have seen, for whatever a single anecdote is worth.
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #103 · Analytics › Method validation · 25 Dec 2024 · 13 likes Robustness testing deliberately varies the parameters most likely to drift — organic percentage, pH, temperature, flow — and shows the result does not. It is the part…
-
How compounding permissions changed when supply normalised Started this topic · Sourcing › Regulatory · 14 Dec 2024 · 0 likes Asking directly, because I could not find a straight answer: How compounding permissions changed when supply normalised I was wrong about compounding permissions in a…
-
[2026 update] New subcategory: rationale and scope Replied, post #61 · Meta › Announcements · 12 Dec 2024 · 17 likes Last note on this: announcements here get more replies than most topics and almost all of them are questions about scope. That is a hint about what an announcement…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #81 · Analytics › Method validation · 26 Nov 2024 · 18 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Blind submission and why it changes minds Replied, post #88 · Sourcing › Independent verification · 15 Oct 2024 · 12 likes Post #86 is right about the mechanism and I think understates the practical bit. Adding a null result on blind submission. I looked, carefully, and found nothing, and…
-
Requesting a page: what makes a good request — what changed since Replied, post #102 · Documentation › Wiki requests · 12 Oct 2024 · 24 likes Translation suggestions: if a maintained page should exist in another language, suggesting it here helps the maintainers prioritise multilingual work. The short version…
-
Why a preprint's supplementary material is often the best part Replied, post #16 · Evidence › Preprints · 8 Sep 2024 · 4 likes Say it is a preprint in the first line rather than the last. Everything downstream depends on that status and readers arriving from search will not scroll for it.…
-
The topic list is dense — is that deliberate? Replied, post #19 · Meta › Site feedback · 28 Aug 2024 · 0 likes Good question, well framed, and I would like to see it answered properly.
-
Tracking a preprint to publication: a worked example — the long version Replied, post #26 · Evidence › Preprints · 14 Aug 2024 · 29 likes Thank you — that answers what I came here to find out.
-
Semaglutide in people without diabetes: what the evidence base looks like Started this topic · Compounds › Semaglutide · 28 Jul 2024 · 7 likes Semaglutide in people without diabetes: what the evidence base looks like Writing it up because I had to work it out twice and would rather nobody else did. What…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #52 · Practice › Dosing & titration · 18 Jul 2024 · 2 likes Building on post #51 rather than restating it. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #5 · Evidence › Preprints · 4 Jun 2024 · 0 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…